Teresa Hagan Thomas, PhD, RNBest Practices | July 10, 2024
Less than half of patients with cancer had caregivers who spoke for more than 4% of a clinical encounter.
Read More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | July 9, 2024
There are 5 types of immune-mediated cytopenias, each with provisional diagnostic criteria.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | July 9, 2024
Nurses have a critical role in managing cGVHD-related serositis, including patient assessment, direct care, and education.
Cecilia BrownLeukemia | July 8, 2024
It is now “first and only” bispecific T-cell engager therapy approved for consolidation treatment regardless of MRD ...
Amanda Brink, DNP, APRN, FNP-BC, AOCNPConferences | July 8, 2024
Learn about the TRANSMET trial and several important nursing considerations.
Katie KoskoConferences | July 5, 2024
Researchers presented real-world data on the cGVHD treatment during the EHA 2024 Congress.
Katie KoskoMyelofibrosis | July 2, 2024
An exploratory analysis of the MOMENTUM trial evaluated how the JAK inhibitor impacted OS and LFS in these patients.
Katie KoskoGI Cancer | June 29, 2024
The CheckMate 9DW clinical trial results support the combination as a potential new first-line standard of care.
Salomon Manier, MD, PhDConferences | July 10, 2024
An expert shares his insights on the challenges and practical considerations that come with bispecific antibody treatment.
Guillermo Garcia-Manero, MDMyelodysplastic Syndrome | June 26, 2024
National Cancer Survivors Month is marked in June each year.
Christophe Willekens, MDConferences | July 8, 2024
Hear expert insights on managing treatment for these patients and the key signs and symptoms to monitor.
Fatemeh Youssefi, PhD, RN, OCNGI Cancer | May 30, 2024
It’s critical to consider the patient’s life, experiences, and preferences in a holistic sense.
Cecilia BrownMultiple Myeloma | May 23, 2024
Talquetamab is a T-cell redirecting bispecific antibody targeting GPRC5D on myeloma cells.
Teresa Hagan Thomas, PhD, RNNews | May 20, 2024
A new study illuminates the experiences of nurses caring for patients at the end of life.
Alicia Michaelsen, BSN, RN, BMTCN®Patient Voice | May 15, 2024
Sexual side effects are common in patients undergoing stem cell transplant but, unfortunately, often go unaddressed.
Cecilia BrownPatient Voice | May 8, 2024
Patients receiving the combination therapy also required lower steroid doses than those receiving temozolomide alone.
Cecilia BrownConferences | April 29, 2024
The management plan for investigational CAR-T showed benefits in multiple domains.
Cecilia BrownConferences | April 26, 2024
Learn how a team developed a strategy to effectively increase nurse knowledge and use of patient support resources.
Andrea Wagner, MSN, RN, OCNConferences | April 26, 2024
Andrea Wagner, MSN, RN, OCN, speaks about her ONS Congress presentation on the development of the workflow.
Cecilia BrownConferences | April 26, 2024
Learn how nurse coordinators identified strategies that could help patients manage multiple symptoms.